Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05965284 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 28, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study is a prospective, open-labelled, randomized, controlled, single-center clinical trial. The aim of this study is to compare the remission rate of patients treated with Telitacicept combined with azathioprine and azathioprine alone in remission-maintenance treatment of AAV.
Trial Details
NCT Number NCT05965284
Lead Sponsor Chinese SLE Treatment And Research Group
Conditions
(from sponsor)		 ANCA-associated Vasculitis, Maintenance Therapy
Related terms Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov